Capricor Therapeutics (CAPR) News Today $11.15 +0.97 (+9.53%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$11.16 +0.00 (+0.04%) As of 06/27/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CAPR Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Oppenheimer & Co. Inc. Buys 24,964 Shares of Capricor Therapeutics, Inc. (NASDAQ:CAPR)3 hours ago | marketbeat.comCapricor Therapeutics (NASDAQ:CAPR) Stock Rating Upgraded by B. RileyJune 28 at 2:14 AM | americanbankingnews.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPRJune 27 at 5:10 PM | prnewswire.comCapricor Therapeutics (NASDAQ:CAPR) Stock Price Up 7.2% - Time to Buy?June 27 at 1:39 PM | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPRJune 27 at 10:00 AM | prnewswire.comCapricor Therapeutics (NASDAQ:CAPR) Rating Increased to Strong-Buy at B. RileyJune 27 at 5:55 AM | marketbeat.comHBK Sorce Advisory LLC Buys Shares of 49,844 Capricor Therapeutics, Inc. (NASDAQ:CAPR)June 27 at 4:43 AM | marketbeat.comB. Riley Securities Initiates Coverage of Capricor Therapeutics (CAPR) with Buy RecommendationJune 26 at 11:23 PM | msn.comJones Trading Issues Pessimistic Forecast for Capricor Therapeutics (NASDAQ:CAPR) Stock PriceJune 25, 2025 | marketbeat.comHC Wainwright Reaffirms Buy Rating for Capricor Therapeutics (NASDAQ:CAPR)June 25, 2025 | americanbankingnews.comOppenheimer Issues Pessimistic Forecast for Capricor Therapeutics (NASDAQ:CAPR) Stock PriceJune 25, 2025 | americanbankingnews.comCapricor Therapeutics Shares Climb After FDA Says Panel Meeting Not NeededJune 24, 2025 | marketwatch.comCapricor Therapeutics Says FDA May Not Hold Advisory Committee Meeting For DMD Therapy Approval: Stock Soars But Analyst Issues WarningJune 24, 2025 | msn.comCapricor says US FDA may not convene expert panel for co's cell therapyJune 24, 2025 | msn.comCapricor Therapeutics' (CAPR) "Buy" Rating Reiterated at HC WainwrightJune 24, 2025 | marketbeat.comUS FDA will not convene expert panel for Capricor Therapeutics' DMD cell therapyJune 24, 2025 | reuters.comBrokerages Set Capricor Therapeutics, Inc. (NASDAQ:CAPR) Target Price at $35.50June 24, 2025 | americanbankingnews.comCapricor Therapeutics (NASDAQ:CAPR) Price Target Cut to $22.00 by Analysts at OppenheimerJune 23, 2025 | marketbeat.comWhy Is Capricor Therapeutics Stock Trading Lower On Monday?June 23, 2025 | benzinga.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPRJune 22, 2025 | prnewswire.comCapricor Therapeutics announces four-year data from HOPE-2 OLE studyJune 21, 2025 | finance.yahoo.comCapricor Therapeutics stock plunges after key FDA officials placed on leaveJune 20, 2025 | in.investing.comCapricor falls after report on AdCom meeting cancellation (update)June 20, 2025 | msn.comCapricor Stock Slumps 16% On Report Of Key FDA Executive’s Removal, But Retail’s Hopeful About New 4-Year Deramiocel DataJune 20, 2025 | msn.comCapricor Reports 4-Year Data For Deramiocel, Shows Sustained Benefit In Duchenne PatientsJune 20, 2025 | benzinga.comCapricor Therapeutics Announces Positive 4-Year Data from HOPE-2 Open-Label Extension Study of Deramiocel in Duchenne Muscular DystrophyJune 20, 2025 | globenewswire.comCapricor Therapeutics, Inc. (NASDAQ:CAPR) Receives Average Rating of "Buy" from BrokeragesJune 19, 2025 | marketbeat.comCapricor Therapeutics (NASDAQ:CAPR) Earns Buy Rating from Roth CapitalJune 19, 2025 | americanbankingnews.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPRJune 18, 2025 | globenewswire.comCapricor gets FDA's Orphan Drug status for muscle disorder therapyJune 17, 2025 | msn.comCapricor Therapeutics (NASDAQ:CAPR) Trading Up 6.8% - Still a Buy?June 17, 2025 | marketbeat.comCapricor Therapeutics (NASDAQ:CAPR) Given "Buy" Rating at Roth CapitalJune 17, 2025 | marketbeat.comDecoding Capricor Therapeutics's Options Activity: What's the Big Picture?June 17, 2025 | benzinga.comCapricor Therapeutics' Becker Muscular Dystrophy Drug Gets Orphan Drug Designation in U.S.June 17, 2025 | marketwatch.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPRJune 17, 2025 | prnewswire.comCapricor Therapeutics Announces Orphan Drug Designation for Becker Muscular Dystrophy and Regulatory Progress for Duchenne Muscular Dystrophy ProgramJune 17, 2025 | globenewswire.comCapricor Therapeutics Sees Unusually High Options Volume (NASDAQ:CAPR)June 13, 2025 | marketbeat.comCapricor says FDA inspection brought Form 483 with several observationsJune 12, 2025 | finance.yahoo.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPRJune 12, 2025 | prnewswire.comCalifornia State Teachers Retirement System Raises Position in Capricor Therapeutics Inc (NASDAQ:CAPR)June 12, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Takes $462,000 Position in Capricor Therapeutics Inc (NASDAQ:CAPR)June 12, 2025 | marketbeat.comCapricor: A Hold Rating With Regulatory FDA Form Given For Deramiocel AdvancementJune 11, 2025 | seekingalpha.comFDA Completes Inspection of Capricor Therapeutics Manufacturing Facility For Deramiocel Approval: Retail Sees ‘Unimaginable Potential’June 11, 2025 | msn.comCapricor Therapeutics stock falls after FDA inspection of manufacturing facilityJune 11, 2025 | in.investing.comCapricor falls after facility inspection related to deramiocelJune 11, 2025 | msn.comCapricor Therapeutics Announces Key Regulatory Updates for its Duchenne Muscular Dystrophy ProgramJune 11, 2025 | globenewswire.comBehind the Scenes of Capricor Therapeutics's Latest Options TrendsJune 11, 2025 | benzinga.comAnalysts Issue Forecasts for CAPR FY2026 EarningsJune 10, 2025 | marketbeat.comCapricor Therapeutics (NASDAQ:CAPR) Trading Down 6.8% - Time to Sell?June 9, 2025 | marketbeat.comWellington Management Group LLP Purchases New Position in Capricor Therapeutics Inc (NASDAQ:CAPR)June 8, 2025 | marketbeat.com Get Capricor Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CAPR and its competitors with MarketBeat's FREE daily newsletter. Email Address CAPR Media Mentions By Week CAPR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CAPR News Sentiment▼0.260.94▲Average Medical News Sentiment CAPR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CAPR Articles This Week▼256▲CAPR Articles Average Week Get Capricor Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CAPR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AHCO News Today NEOG News Today BLFS News Today PAHC News Today INMD News Today KMTS News Today CBLL News Today EOLS News Today OMI News Today MRVI News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CAPR) was last updated on 6/29/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Capricor Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Capricor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CAPR Stock Free CAPR Stock Alerts